EURAM LIMITED - United Kingdom 

Ranking results:

Past rankings:

2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:500-600
Total Number of Projects:68
Total Project Funding:800-900
Networking Rank (Reputation):900-1000
Networking Rank (Reputation):900-1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 12
As coordinator: 0
As participant: 12
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 13.437.639 142.771 2
2015 0 7.994.746 83.680 1
2014 0 4.500.962 253.760 1
2013 0 14.502.336 822.281 2
2012 0 13.711.632 1.529.534 3
2011 0 5.993.083 257.300 1
2010 0 9.629.064 489.127 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY COLLEGE LONDON8
ITAE SUOMEN YLIOPISTO3
KATHOLIEKE UNIVERSITEIT LEUVEN3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
FINVECTOR VISION THERAPIES LIMITED2
INSTITUT CATALA DE LA SALUT2
KAROLINSKA INSTITUTET2
LUNDS UNIVERSITET2
MAGNUS INVENTION MANAGEMENT2
UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST2
A2F ASSOCIATES LIMITED1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACADEMISCH ZIEKENHUIS LEIDEN1
ALMAC DIAGNOSTICS LIMITED1
BIOCONTRACT SP ZOO1
CARDIO3 BIOSCIENCES1
CARDIOVASCULAR RESEARCH CENTER AALST VZW1
CELL THERAPY CATAPULT LIMITED1
CELLPROTECT NORDIC PHARMACEUTICALS AB1
CELYAD1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
COSMOPHOS1
DUBLIN CITY COUNCIL1
ENERGY MANAGEMENT AND INFORMATION TECHNOLOGY CONSULTANTS S A1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ESI GROUP S A1
EUROFINS GENOMICS EUROPE SEQUENCING1
FAKULTNI NEMOCNICE BRNO1
FIBERTECH CO1
FLORENCE ENGINEERING1
FREIE UNIVERSITAET BERLIN1
FUJIKURA EUROPE1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
GATC BIOTECH1
GAZ DE FRANCE1
GENEDATA1
GKSS FORSCHUNGSZENTRUM GEESTHACHT1
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST1
HELSE BERGEN HFHAUKELAND UNIVERSITY HOSPITAL1
I D S INGEGNERIA DEI SISTEMI S P A1
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE1
INSTITUT KLINICKE A EXPERIMENTALNI MEDICINY1
INSTYTUT GRUZLICY I CHOROB PLUC1
ISTITUTO EUROPEO DI ONCOLOGIA1
ISTITUTO ORTOPEDICO RIZZOLI1
ITASUOMEN YLIOPISTO1
J & P GEO SARL1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
KING'S COLLEGE HOSPITAL NHS TRUST1
KING'S COLLEGE LONDON1
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET1
KLINIKUM DER UNIVERSITAET ZU KOELN1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
KONRADZUSEZENTRUM FUER INFORMATIONSTECHNIK BERLIN1
KUOPIO UNIVERSITY HOSPITAL1
LEIDEN UNIVERSITY MEDICAL CENTER1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER1
LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN1
MANCHESTER UNIVERSITY NHS FOUNDATION TRUST1
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV1
MEDIS SPECIALS BV1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDSCINET AB1
MICHAELSTUART FARRIMOND MICHAELSTUART1
NATIONAL HELLENIC RESEARCH FOUNDATION1
NHS BLOOD AND TRANSPLANT1
NORDIC HEALTH ECONOMICS AB1
ONCOTYROLCENTER FOR PERSONALIZED CANCER MEDICINE1
OPSONA THERAPEUTICS1
OSLO UNIVERSITETSSYKEHUS HF1
OSYS TECHNOLOGY LIMITED1
QUALIMED INNOVATIVE MEDIZINPRODUKTE1
REGION HOVEDSTADEN1
RESCOLL1
SCS1
SEMMELWEIS EGYETEM1
SERVICIO MADRILENO DE SALUD1
SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH1
STATICE SAS1
STICHTING KATHOLIEKE UNIVERSITEIT1
T2CURE1
TECHNISCHE UNIVERSITAET MUENCHEN1
TECHNISCHE UNIVERSITEIT DELFT1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE UNIVERSITY OF EXETER1
THE UNIVERSITY OF MANCHESTER1
TMC PHARMA SERVICES LIMITED1
TOXICOOP TOXIKOLOGIAI KUTATO KOZPONT ZARTKORUEN MUKODO RT1
TRACTO TECHNIK1
UNIVERSIDAD AUTONOMA DE MADRID1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA DEGLI STUDI DI BRESCIA1
UNIVERSITAET ROSTOCK1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1

Constancy:

Total number of partners: 132
Partner loyalty:
Frequent Partner: (> 2 projects): 17
Rare Partner: 115
Frequent / Rare Partner Ratio: 0.15

Project overview:

Start dateProjectacronymrolefundingpartners
2016-01-01Autologous Stem Cell Seeded Tissue Engineered Trachea TETRAparticipant6.828.88414
2016-01-01Boost Brittle Bones Before Birth BOOSTB4participant6.608.75513
2015-09-01Female cancer prediction using cervical omics to individualise screening and prevention FORECEEparticipant7.994.74614
2014-01-01Tissue engineering of the right heart outflow tract by a biofunctionalized bioresorbable polymeric valved tube TEH-TUBEparticipant4.500.9627
2013-03-01Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease COSMOPHOS-NANOparticipant8.503.35219
2013-01-01Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction? EVERRESTparticipant5.998.98410
2012-11-01EPIGENETICS FOR FEMALE PERSONALIZED CANCER CARE EPI-FEM-CAREparticipant5.875.3876
2012-10-01Operational Radar For Every drill string Under the Street ORFEUSparticipant2.536.76711
2012-01-01Biodegradable Magnetic Stent for Coronary Artery Luminal Regeneration BIOMAGSCARparticipant5.299.4788
2011-11-01The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction BAMIparticipant5.993.08322
2010-12-01Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation MABSOTparticipant5.929.06410
2010-01-01Enhanced patient safety by computational Modelling from clinically available X-rays to minimise the risk of overload and instability for optimised function and joint Longevity MXLparticipant3.700.00010